The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other rinsing solutions in patients with oral mucositis after allogeneic stem cells transplantation

被引:23
作者
Vokurka, Samuel [1 ]
Skardova, Jana [1 ]
Hruskova, Renata [2 ]
Kabatova-Maxova, Klara [1 ]
Svoboda, Tomas [1 ]
Bystricka, Eva [1 ]
Steinerova, Katerina
Koza, Vladimir [1 ]
机构
[1] Univ Hosp Plzen, Dept Haematooncol, Plzen 30460, Czech Republic
[2] Univ Hosp Plzen, Dept Microbiol, Plzen 30460, Czech Republic
来源
MEDICAL SCIENCE MONITOR | 2011年 / 17卷 / 10期
关键词
Gelclair; oral mucositis; pain; nursing; Enterococcus; Candida; microbiology; CLINICAL-PRACTICE GUIDELINES; INDUCED STOMATITIS; PREVENTION; PROPHYLAXIS; CRYOTHERAPY; THERAPY;
D O I
10.12659/MSM.881983
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Gelclair is an oral lubricating gel used in the management of oral mucositis (OM). We evaluated its efficacy, tolerance and impact on oral cavity microbial colonization in patients with OM after allogeneic hematopoietic stem cells transplantation. Material/Method: Gelclair was administered in a group of 22 patients with active OM. A control group of 15 patients used other rinsing solutions (chlorhexidine, benzydamine, salvia). Tests with oral cavity swabs for microbiology analysis were performed once a week. Results: The characteristics of OM in both groups were comparable, and rinsing solutions had satisfactory tolerability. There was no difference in the median improvement of oral intake and OM-related pain relief, which was assessed mostly as "slight effect". In the Gelclair group, the effect duration was longer (median 3 [0-5] vs. 1 [0-3] hours, p=0.001). There was significant increase of Enterococcus faecalis and Candida sp. colonization of the oral cavity over the course of the hospitalization and significantly reduced incidence of such colonization in patients with OM in the Gelclair group: 1/22 (5%) vs. 6/15 (40%), p=0.01. In vitro tests showed inhibited growth of Enterococcus faecalis and Candida sp. colonies within the area of the Gelclair application. Conclusions: Gelclair may be individually helpful in the management of OM and pain in patients after allogeneic stem cells transplantation. Its use did not lead to worsened oral bacterial and yeast colonization and probably even helped to protect mucosa from Enterococcus and Candida sp. Further studies based on larger cohorts are needed.
引用
收藏
页码:CR572 / CR576
页数:5
相关论文
共 17 条
[1]   Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients [J].
Aisa, Y ;
Mori, T ;
Kudo, M ;
Yashima, T ;
Kondo, S ;
Yokoyama, A ;
Ikeda, Y ;
Okamoto, S .
SUPPORTIVE CARE IN CANCER, 2005, 13 (04) :266-269
[2]  
[Anonymous], 2008, J NATL COMPRE CANC N, DOI DOI 10.6004/JNCCN.2008.0001
[3]   Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis [J].
Barber, Claire ;
Powell, Roy ;
Ellis, Annie ;
Hewett, Julie .
SUPPORTIVE CARE IN CANCER, 2007, 15 (04) :427-440
[4]  
BONASSI L, 2003, ANN ONCOL, V14, P58
[5]   Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair®): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions [J].
Buchsel, Patricia C. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (11) :1449-1454
[6]   Antimicrobial therapy to prevent or treat oral mucositis [J].
Donnelly, JP ;
Bellm, LA ;
Epstein, JB ;
Sonis, ST ;
Symonds, RP .
LANCET INFECTIOUS DISEASES, 2003, 3 (07) :405-412
[7]   CHLORHEXIDINE PROPHYLAXIS FOR CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED STOMATITIS - A RANDOMIZED DOUBLE-BLIND TRIAL [J].
FERRETTI, GA ;
RAYBOULD, TP ;
BROWN, AT ;
MACDONALD, JS ;
GREENWOOD, M ;
MARUYAMA, Y ;
GEIL, J ;
LILLICH, TT ;
ASH, RC .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1990, 69 (03) :331-338
[8]  
Flook C, 2005, SUPPORT CARE CANCER, V13, P443
[9]   Efficacy of Gelclair in reducing pain in palliative care patients with oral lesions: Preliminary findings from an open pilot study [J].
Innocenti, M ;
Moscatelli, G ;
Lopez, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (05) :456-457
[10]   Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - are there new strategies? [J].
Karthaus, M ;
Rosenthal, C ;
Ganser, A .
BONE MARROW TRANSPLANTATION, 1999, 24 (10) :1095-1108